Thermo Fisher Scientific Inc. (ETR:TN8)
Germany flag Germany · Delayed Price · Currency is EUR
352.50
+4.55 (1.31%)
Jun 3, 2025, 5:35 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Life Sciences Solutions
9.69B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Solutions Growth
0.38%
Log In
Log In
Log In
Log In
Upgrade
Analytical Instruments
7.49B
Log In
Log In
Log In
Log In
Upgrade
Analytical Instruments Growth
3.69%
Log In
Log In
Log In
Log In
Upgrade
Specialty Diagnostics
4.55B
Log In
Log In
Log In
Log In
Upgrade
Specialty Diagnostics Growth
3.29%
Log In
Log In
Log In
Log In
Upgrade
Laboratory Products and Biopharma Services
23.07B
Log In
Log In
Log In
Log In
Upgrade
Laboratory Products and Biopharma Services Growth
0.32%
Log In
Log In
Log In
Log In
Upgrade
Consumables
17.61B
Log In
Log In
Log In
Log In
Upgrade
Consumables Growth
1.11%
Log In
Log In
Log In
Log In
Upgrade
Instruments
7.45B
Log In
Log In
Log In
Log In
Upgrade
Instruments Growth
0.95%
Log In
Log In
Log In
Log In
Upgrade
Services
17.84B
Log In
Log In
Log In
Log In
Upgrade
Services Growth
0.80%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Life Sciences Solutions Operating Income
3.50B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Solutions Operating Income Growth
2.10%
Log In
Log In
Log In
Log In
Upgrade
Analytical Instruments Operating Income
1.96B
Log In
Log In
Log In
Log In
Upgrade
Analytical Instruments Operating Income Growth
3.60%
Log In
Log In
Log In
Log In
Upgrade
Specialty Diagnostics Operating Income
1.17B
Log In
Log In
Log In
Log In
Upgrade
Specialty Diagnostics Operating Income Growth
2.72%
Log In
Log In
Log In
Log In
Upgrade
Laboratory Products and Biopharma Services Operating Income
3.08B
Log In
Log In
Log In
Log In
Upgrade
Laboratory Products and Biopharma Services Operating Income Growth
-7.01%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
North America
22.50B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-0.03%
Log In
Log In
Log In
Log In
Upgrade
Europe
10.86B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
0.96%
Log In
Log In
Log In
Log In
Upgrade
Asia-Pacific
7.99B
Log In
Log In
Log In
Log In
Upgrade
Asia-Pacific Growth
3.07%
Log In
Log In
Log In
Log In
Upgrade
Other Regions
1.55B
Log In
Log In
Log In
Log In
Upgrade
Other Regions Growth
4.86%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2019
Total Organic Revenue Growth
Log In
Log In
Log In
Log In
Upgrade
Core Organic Revenue Growth
Log In
Log In
Log In
Log In
Upgrade